Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2017 Apr 13;8(4):e2751. doi: 10.1038/cddis.2016.137

APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase

Xiaoxiao Peng, Mei-Qiong-Zi Zhang, Francesca Conserva, Gihan Hosny, Galina Selivanova, Vladimir JN Bykov, Elias SJ Arnér, Klas G Wiman
PMCID: PMC5477569  PMID: 28406483

Correction to: Cell Death and Disease (2013) 4, e881; doi:10.1038/cddis.2013.417; published online 24 October 2013.

After publication of this paper in Cell Death and Disease in 2013, the authors noted an error contained in Figure 3a, in that, the beta-actin blot for the 48 h time point was by mistake duplicated for the 72 and 96 h time points. The correct beta-actin blots for 72 and 96 h are now included in the figure given here.

Figure 3.

Figure 3

siRNA knockdown of TrxR1 inhibits APR-246-induced cell death. (a) Two different siRNAs against TrxR1 (TrxR1-siRNA-1 and TrxR1-siRNA-2) inhibited TrxR1 expression in H1299 and H1299-His175 cells for at least 72 h. (b) H1299-His175 cells treated either with scrambled siRNA or a combination of scrambled siRNA and APR-246, or with TrxR1-siRNA-2 and APR-246. DNA content was assessed by flow cytometry. (c) Quantification of the sub-G1 cell population. Data are means±S.E., n=4


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES